Platinum Investment Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Platinum Investment Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-248,462	Closed	-$1.92M	–	158
2023 Q3	$1.92M	Hold	248,462	–	–	0.07%	81
2023 Q2	$1.29M	Buy	248,462 +129,334	+109%	+$659K	0.04%	90
2023 Q1	$640K	Buy	+119,128	New	+$648K	0.02%	107
2022 Q1	–	Sell	-133,517	Closed	-$1.76M	–	149
2021 Q4	$1.76M	Buy	133,517 +25,685	+24%	+$425K	0.05%	97
2021 Q3	$2.48M	Buy	107,832 +32,621	+43%	+$970K	0.07%	91
2021 Q2	$3.3M	Buy	75,211 +12,614	+20%	+$703K	0.08%	78
2021 Q1	$4.54M	Sell	62,597 -5,000	-7%	-$355K	0.1%	57
2020 Q4	$2.92M	Buy	67,597 +26,399	+64%	+$1.18M	0.07%	74
2020 Q3	$1.69M	Buy	41,198 +5,496	+15%	+$284K	0.04%	85
2020 Q2	$2.14M	Buy	35,702 +21,819	+157%	+$2M	0.05%	83
2020 Q1	$1.04M	Buy	+13,883	New	+$1.6M	0.03%	97

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Platinum Investment Management's ORTX Position: Q4 2023 in Review

Platinum Investment Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 248,462 shares — an estimated $1.92M sold.

Platinum Investment Management first reported a position in ORTX in Q1 2020 and held it in 11 quarters. The position peaked at $4.54M in Q1 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

Platinum Investment Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Platinum Investment Management sold 248,462 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $1.92M.
Platinum Investment Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 11 quarters.
Platinum Investment Management's Orchard Therapeutics plc American Depositary Shares position peaked at $4.54M in Q1 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Platinum Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.